GNA Biosolutions
GNA Biosolutions is a private molecular diagnostics company.
GNA Biosolutions has raised €12M across 1 funding round from 1 investor, most recently a Series C round in Jul 2019. Based in Munich, Germany; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€12M
€11,862,917
Funding rounds
1
Investors
1
distinct backers
Active since
2019-07
latest 2019-07
Funding by year
EUR raised per yearGNA Biosolutions — funding by year — interactive chart.
Data table
| GNA Biosolutions — funding by year | |
|---|---|
| 2019 | €12M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series C | €12M | GreyBird Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData